HealthDay News — Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at 12 months after multifood oral immunotherapy (mOIT) or omalizumab, ...
The incidence of CSCC and CIS increased while the incidence of KA decreased, with sex-, age-, and site-specific differences observed.
Mycophenolate mofetil is associated with comparable treatment outcomes to methotrexate among patients with juvenile localized scleroderma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results